RESUMEN
PURPOSE: We examined emotional distress in cancer survivors diagnosed as adolescents or young adults (AYAs) versus cancer survivors diagnosed as middle/older adults and versus the general population without a history of cancer. METHODS: Using the 2014-2017 National Health Interview Surveys, 2500 AYA survivors (initial cancer diagnosed between aged 15-39 years) were matched with 2500 middle/older adult survivors (initial cancer diagnosed at aged ≥40 years) as well as with 1609 from the general population without a history of cancer. Multinomial logistic regression models estimated the risk of emotional distress (measured using the validated Kessler distress (K6) scale) in the study population (AYA vs. middle/older adult cancer survivors and vs. general population without cancer), adjusting for known covariates. RESULTS: Emotional distress was more prevalent among AYAs (average age 52.8 ± 19.1 years) than middle/older adult (average age 67.4 ± 14.0 years) cancer survivors (moderate: 25.5% vs. 19.4%; and severe: 6.4% vs. 4.4% [P < .0001]); however, there was no difference in emotional distress between AYA cancer survivors (moderate: 26.8% and severe: 7.5%) versus general population without cancer (moderate: 23.7% and severe: 6.2%). In the multivariable multinomial analyses, AYA cancer survivors had higher risk of reporting emotional distress (adjusted relative risk = 1.45; 95% confidence interval = 1.13-1.86) than middle/older adult cancer survivors. CONCLUSION: Psychosocial support may be especially needed for cancer survivors diagnosed as adolescents or young adults to mitigate adverse psychosocial outcomes.
Asunto(s)
Supervivientes de Cáncer , Neoplasias , Distrés Psicológico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Supervivientes de Cáncer/psicología , Humanos , Persona de Mediana Edad , Neoplasias/epidemiología , Encuestas y Cuestionarios , Sobrevivientes/psicología , Adulto JovenRESUMEN
OBJECTIVES: To quantify head and neck cancer (HNC) mortality rates and identify racial and socioeconomic factors associated with 90-day mortality. METHODS: The National Cancer Database (2004-2014) was queried for eligible HNC cases (nâ¯=â¯260,011) among adults treated with curative intent. Outcome of interest was any-cause 90-day mortality. Kaplan-Meier curves (Log-rank tests) estimated crude survival differences. A Cox proportional hazards model with further adjustments using the Sidák multiple comparison method adjusted for racial, socioeconomic and clinical factors. RESULTS: There were 9771 deaths (90-day mortality rateâ¯=â¯3.8%). There were crude differences in sex, race/ethnicity, comorbidity, distance, income, and insurance (Log-rank p-valueâ¯<â¯0.0001). In the final model, blacks (aHRâ¯=â¯1.10, 95% CI 1.00, 1.21) and males (aHRâ¯=â¯1.07; 95% CI 1.00, 1.15) had greater 90-day mortality hazard, as did those uninsured (aHRâ¯=â¯1.72; 95% CI 1.48, 1.99), covered by Medicaid (aHRâ¯=â¯1.72; 95% CI 1.53, 1.93) or Medicare (aHRâ¯=â¯1.40; 95% CI 1.27, 1.53). Residence in lower median income zip code was associated with greater 90-day mortality [(aHR <$30,000â¯=â¯1.30; 95% CI 1.18, 1.44); (aHR $30,000-$34,999â¯=â¯1.24; 95% CI 1.13, 1.36); (aHR $35,000-$45,999â¯=â¯1.18; 95% CI 1.08, 1.27)]; and farther travel distance for treatment was associated with decreased 90-day mortality [(aHR 50-249.9 milesâ¯=â¯0.86; 95% CI 0.77, 0.97); (aHRâ¯>â¯250 milesâ¯=â¯0.70; 95% CI 50, 0.99)]. CONCLUSIONS: There are significant race and socioeconomic disparities among patients with HNC, and these disparities impact mortality within 90â¯days of treatment.
Asunto(s)
Neoplasias de Cabeza y Cuello/epidemiología , Disparidades en Atención de Salud/tendencias , Anciano , Femenino , Neoplasias de Cabeza y Cuello/mortalidad , Humanos , Masculino , Persona de Mediana Edad , Grupos Raciales , Factores Socioeconómicos , Factores de Tiempo , Estados UnidosRESUMEN
OBJECTIVES/HYPOTHESIS: Radiation is thought to increase risk of developing second primary thyroid cancer (SPTC). This study estimated the rate of SPTC following index head and neck cancer (HNC) and determined whether radiation treatment among HNC survivors increased SPTC risk. STUDY DESIGN: Retrospective data analysis. METHOD: The Surveillance, Epidemiology, and End Results database (1975-2014) was queried for cases of index HNC (N = 127,563) that developed SPTC. Adjusted multivariable competing risk proportional hazards model tested risk of developing a SPTC following index HNC. Sensitivity analyses using proportional hazards models were also performed restricting data to patients who 1) received both radiation and chemotherapy and 2) radiation alone. RESULTS: Only 0.2% of index HNC survivors (n = 229) developed SPTC, yielding a rate of 26.1 per 100,000 person-years. For every increasing year of age at diagnosis, patients were 3% less likely to develop an SPTC (adjusted hazard ratio [aHR] = 0.97, 95% CI: 0.96-0.98). Males were also less likely to develop an SPTC (aHR = 0.73, 95% CI: 0.55-0.96). Radiation (aHR = 0.92, 95% CI: 0.68-1.25), surgery (aHR = 0.79, 95% CI: 0.56-1.11), and chemotherapy (aHR = 1.13, 95% CI: 0.76-1.69) were not significantly associated with developing SPTC. The sensitivity models also did not find an association between treatment and risk of SPTC. CONCLUSIONS: Rate of developing SPTC following index HNC was very low, and previous exposure to radiation did not significantly increase risk in our study population. More studies are needed to understand the increasing incidence of thyroid cancer across the United States. LEVEL OF EVIDENCE: NA Laryngoscope, 129:1014-1020, 2019.
Asunto(s)
Neoplasias de Cabeza y Cuello/radioterapia , Neoplasias Inducidas por Radiación/etiología , Neoplasias Primarias Secundarias/etiología , Neoplasias de la Tiroides/etiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Inducidas por Radiación/epidemiología , Neoplasias Primarias Secundarias/epidemiología , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Neoplasias de la Tiroides/epidemiologíaRESUMEN
Innate immunity provides the initial response against pathogens and includes the inflammatory response. Regulation of the initiation and duration of neutrophil and mononuclear cell influx during inflammation determines both the successfulness of pathogen elimination and the level of resulting tissue damage. Zebrafish embryos provide excellent opportunities to visualize the inflammatory response. Neutrophil granules may be stained with Sudan black, and variation in neutrophil counts may be used to monitor the level of the response. Inflammation may be triggered by injuring the caudal fin, providing an opportunity for testing possible anti-inflammatory compounds in a whole-animal system. The use of homeopathic compounds as anti-inflammatory treatments is common in alternative medicine. Effects of unfractionated essential oil from Thymus vulgaris and its specific component, carvacrol, have been examined in cells in culture and in rodents. Our work extends this research to zebrafish, and includes toxicity and morphological studies as well as examination of anti-inflammatory effects following tail fin injury. Our results show that zebrafish are more sensitive to thyme oil compared to cells in culture, that cardiac defects arise due to thyme oil treatment, and that thyme oil reduces neutrophil infiltration during an inflammatory response.